In India, the burden of cardiovascular disease (CVD) surpasses global averages significantly. With an age-standardized death rate of 282 deaths/100,000 for CVD, India exceeds the global rate of 233 deaths/100,000. Moreover, CVD-related age-standardized DALY rates in India are 1.3 times the global average, contributing significantly to global DALYs for ischemic heart disease (IHD), stroke, and rheumatic heart disease. Indians experience CVD a decade earlier than those of European ancestry, with two-thirds of cardiovascular deaths occurring prematurely. Factors such as education, socio-economic status, and physiological differences, including higher insulin resistance and prevalence of diabetes, contribute to this heightened risk. Despite these challenges, treatment and control levels for hypertension and diabetes remain low in India, underscoring the urgent need for comprehensive intervention strategies.
What is Clopibond CV?
Clopibond CV is a combination medication used to reduce the risk of cardiovascular events such as heart attacks and stroke. It contains two active ingredients: Clopidogrel 75mg and Rosuvastatin 10mg or 20mg. This combination helps prevent blood clots and lower cholesterol levels, two key factors in reducing the risk of heart disease.
How Does Clopibond CV Work?
Each component of Clopibond CV serves a specific purpose:
Benefits of Clopibond CV
Talk to your doctor to know more on CLOPIBOND CV
REUEL PHARMACEUTICALS
52/3216 - A Vembully Lane, Vyttila, Cochin, Ernakulam, Kerala 682019 | Kootezhath Bldg, Kuvempu Layout, Hebbal-Kempapura, Bangalore-560024
Copyright © 2024 REUEL PHARMACEUTICALS - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.